BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 17700925)

  • 1. Octreotide: a therapeutic option for idiopathic intracranial hypertension.
    Panagopoulos GN; Deftereos SN; Tagaris GA; Gryllia M; Kounadi T; Karamani O; Panagiotidis D; Koutiola-Pappa E; Karageorgiou CE; Piadites G
    Neurol Neurophysiol Neurosci; 2007 Jul; ():1. PubMed ID: 17700925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion and diffusion magnetic resonance imaging in idiopathic intracranial hypertension.
    Bicakci K; Bicakci S; Aksungur E
    Acta Neurol Scand; 2006 Sep; 114(3):193-7. PubMed ID: 16911348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide: The IIH therapy beyond weight loss, carbonic anhydrase inhibitors, lumbar punctures and surgical/interventional treatments.
    House PM; Stodieck SR
    Clin Neurol Neurosurg; 2016 Nov; 150():181-184. PubMed ID: 27690252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser scanning tomography measurement of the extent of papilledema in the follow-up examination of patients with idiopathic intracranial hypertension.
    Heckmann JG; Faschingbauer F; Lang C; Reulbach U; Dütsch M; Mardin CY; Schwab S
    J Neurosurg; 2007 Sep; 107(3):543-7. PubMed ID: 17886553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between idiopathic intracranial hypertension and obesity.
    Hannerz J; Ericson K
    Headache; 2009 Feb; 49(2):178-84. PubMed ID: 19222591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant idiopathic intracranial hypertension.
    Thambisetty M; Lavin PJ; Newman NJ; Biousse V
    Neurology; 2007 Jan; 68(3):229-32. PubMed ID: 17224579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.
    Shah VA; Kardon RH; Lee AG; Corbett JJ; Wall M
    Neurology; 2008 Feb; 70(8):634-40. PubMed ID: 18285538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients.
    Donnet A; Metellus P; Levrier O; Mekkaoui C; Fuentes S; Dufour H; Conrath J; Grisoli F
    Neurology; 2008 Feb; 70(8):641-7. PubMed ID: 18285539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ophthalmoparesis in idiopathic intracranial hypertension.
    Bruce BB; Newman NJ; Biousse V
    Am J Ophthalmol; 2006 Nov; 142(5):878-80. PubMed ID: 17056379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic intracranial hypertension in Dubai: nature and prognosis.
    Mezaal M; Saadah M
    Acta Neurol Scand; 2005 Nov; 112(5):298-302. PubMed ID: 16218911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic intracranial hypertension in pregnancy.
    Huna-Baron R; Kupersmith MJ
    J Neurol; 2002 Aug; 249(8):1078-81. PubMed ID: 12195458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudotumor cerebri in children with Down syndrome.
    Esmaili N; Bradfield YS
    Ophthalmology; 2007 Sep; 114(9):1773-8. PubMed ID: 17368546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Benign intracranial hypertension. Retrospective study of 20 cases].
    Merle H; Smadja D; Ayeboua L; Cabre P; Gerard M; Alliot E; Rapoport P; Jallot-Sainte-Rose N; Richer R; Poman G
    J Fr Ophtalmol; 1998 Jan; 21(1):42-50. PubMed ID: 9834899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of presentation and course of idiopathic intracranial hypertension--a large cohort comprehensive study.
    Pollak L; Zohar E; Glovinsky Y; Huna-Baron R
    Acta Neurol Scand; 2013 Jun; 127(6):406-12. PubMed ID: 23278763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Idiopathic intracranial hypertension and tetracycline].
    Weller B; Sharf B; Sierpinski-Barth J; Schwartz M
    Harefuah; 1994 Jul; 127(1-2):9-11, 64. PubMed ID: 7959395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resolution of headache and papilledema in idiopathic intracranial hypertension associated with inhibition of Na+-K+-2Cl- cotransport.
    Kahle KT; Walcott BP; Staley KJ
    J Child Neurol; 2011 Feb; 26(2):205-8. PubMed ID: 21285039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical variants of pseudotumor cerebri syndrome].
    Koepp M; Lempert T; Poewe W
    Nervenarzt; 1995 Jun; 66(6):397-402. PubMed ID: 7637826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Benign intracranial hypertension in childhood--pseudotumor cerebri].
    Kurlemann G; Schuierer G
    Klin Padiatr; 1993; 205(5):340-4. PubMed ID: 8411899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic endonasal management of pseudotumor cerebri: is it effective?
    Gupta AK; Gupta A; Kumar S; Lal V
    Laryngoscope; 2007 Jul; 117(7):1138-42. PubMed ID: 17603312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Benign intracranial hypertension. History, clinical features and treatment in a series of 41 patients].
    Rodríguez de Rivera FJ; Martínez-Sanchez P; Ojeda-Ruiz de Luna J; Arpa-Gutiérrez FJ; Barreiro-Tella P
    Rev Neurol; 2003 Nov 1-15; 37(9):801-5. PubMed ID: 14606044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.